Administration & Agency Updates

Recent Administration & Agency Updates

nihb_blog_default

Vaccines and Boosters Available to Tribal Citizens

There are three U.S. Food and Drug Administration (FDA) authorized COVID-19 vaccines. All three of the available COVID-19 vaccines are safe and effective and reduce your risk of severe illness. Two of them, Pfizer-BioNTech and Moderna, are messenger RNA (mRNA) vaccines. mRNA vaccines teach our cells how to make a protein that will trigger an immune response inside our bodies. The third, Johnson &…
nihb_blog_default

Omicron Variant and Infection Control for Tribal Healthcare Workers

More than 17 states have reported cases of the Omicron variant of COVID-19 since it was first detected in the U.S. last week. Although it is not clear how transmissible Omicron is or how effective existing COVID vaccines are against it, Tribal healthcare workers should continue following infection control practices while providing care within Tribal communities. The Centers for Disease Control and Prevention (CDC)…
nihb_blog_default

Grant Opportunity – Community-Based Workforce to Build COVID-19 Vaccine Confidence, Deadline, December 10, 2021

The Health Resources and Services Administration (HRSA) has released a grant opportunity to strengthen vaccine confidence, provide further information and education on the vaccines, and improve vaccination rates. Eligible applicants are non-profit private or public organizations, including Tribes and Tribal organizations. Estimated total program funding is $66,500,000. HRSA will fund applicants with experience and expertise implementing public health programs across broad geographic areas. The…
nihb_blog_default

President Biden Announces Plan to Combat Delta and Omicron Variants this Winter

As we head into winter, President Biden has detailed the administration’s nine-pronged plan to fight the Omicron and Delta variants while keeping the economy growing. In addition to the mask mandate remaining in effect for all public transportation until March 18, 2022 the U.S. will now require all inbound international travelers to provide a negative COVID-19 test within one day of travel, regardless of…
nihb_blog_default

Biden Administration Secures 10 Million Courses of Pfizer’s COVID-19 Oral Antiviral Medicine

On November 18, 2021, the U.S. Department of Health and Human Services (HHS), announced the Biden administration has secured 10 million courses of the COVID-19 oral antiviral drug Paxlovid from Pfizer. Paxlovid will help to reduce hospitalizations and save lives. This drug can block an enzyme the SARS-CoV-2 virus needs to replicate in human cells. Pfizer is seeking an emergency use authorization (EUA) or…
nihb_blog_default

New COVID-19 Variant Reported in South Africa

On November 26, 2021, the World Health Organization (WHO) classified a new COVID-19 variant, B.1.1.529 as a Variant of Concern and has named it Omicron. This variant was first reported to the WHO by South Africa, but that does not necessarily mean that is where the Omicron variant originated. The South African government and its scientists have openly communicated with the global scientific community…

Contact Us

To reach the NIHB COVID-19 Response Team, please contact [email protected].

For media inquiries, please contact Janee Andrews at [email protected].

© Copyright 2020, National Indian Health Board. All Rights Reserved. Website by DrawBridge Creative.

Privacy Policy

This website is supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $2,000,000 with 70 percent funded by CDC/HHS, and 30 percent funded by non-government source(s). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.